To confirm this, we first examined the presence of SAT1 in different molecular subtypes of breast cancer, and found that SAT1 was extremely abundant in TNBC, compared to ER/PR‐positive or HER2‐positive breast cancers (Figure 1B,C). This evidence concerns the gene SAT1 and breast cancer.